CYPRESS Efficacy and Safety Study Extension

Running, not enrolling · Not applicable

Conditions studied: Juvenile Myopia, Myopia

In brief

This is an open-label, controlled, multisite, two-arm parallel group clinical trial of 36-month duration to evaluate the continued safety and efficacy of SightGlass Vision Diffusion Optics Technology (DOT) Spectacles in reducing the progression of juvenile myopia.

Key facts

Study ID
NCT04947735
Run by
SightGlass Vision, Inc.
People needed
200
Starts
2021-07-19
Expected to finish
2026-12-31
Last updated by the study team
2026-05-05

Who can join

Age: 6 and older, up to 17. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.